In announcing these appointments, OnCURE Chief Executive Officer, Richard Zehner, stated, "We are excited to add three extremely well qualified healthcare executives to our team. OnCURE expects each new executive to provide a valuable contribution to our strategic and operational goals."
Mr. Phillips has 20 years of experience in the practice of law with 14 years of experience in the healthcare industry. Prior to joining OnCURE, he served as the Executive Vice President, General Counsel and Secretary of Alliance Imaging, Inc. (NYSE:AIQ). Mr. Phillips has also served as the Chief Legal Officer of Talbert Medical Management Corporation and Corporate Counsel for FHP International Corporation. Mr. Phillips started his legal career as a corporate associate with the law firm of Skadden, Arps, Slate, Meagher & Flom after serving a clerkship with the Supreme Court of Delaware. Mr. Phillips received his Juris Doctorate degree in 1986 from Washington University School of Law, St. Louis, Missouri.
Mr. Atkins has over 25 years of senior management experience in healthcare, including 15 years as Chief Executive Officer of two leading diagnostic imaging services companies. His experience includes nine years as President and Chief Executive Officer of InSight Health Services Corp., a national diagnostic imaging services company. In addition, Mr. Atkins was the President and Chief Executive Officer of AMI Diagnostic Services for seven years and launched the nation's first mobile CT services company. Mr. Atkins also served as European Marketing Director of Technicare Corporation based in Holland, a manufacturer of imaging equipment and a subsidiary of Johnson and Johnson (NYSE:JNJ). Mr. Atkins holds a BA degree in Biological Sciences from Miami University of Ohio.
Ms. Guerrero has over 29 years of national and international experience in the development and operation of cancer treatment centers and programs. Ms. Guerrero served as the Service Line Director of Cancer and Women's Services at Overlake Hospital Medical Center in Bellevue, Washington for the last five years. Ms. Guerrero has been involved in the development of 43 facilities and has consulted with over 250 programs in the U.S. and abroad. She has also held the positions of Assistant Vice President, South American Operations of Healthcare Technologies International; Senior Vice President, Cancer Center Operations of Physician Health Corporation; Associate Director of Administration of UCSD Cancer Center and Medical Center; President of MedLink Systems; and Executive Vice President Cancer Center Operations for CDP Associates.
About OnCURE
OnCURE, headquartered in Newport Beach, California, owns, operates and manages 32 radiation centers, and other mobile HDR & PET CT units, all located in California and Florida. The Company believes they are one of the largest operators of freestanding radiation centers in the country. OnCURE's centers provide treatment areas and equipment for radiation therapy and diagnostic radiology, including IMRT, CT, and PET. OnCURE does not own physician practices nor does it maintain any control over the provision of medical services at its centers. OnCURE does, however, provide capital, technology, and management expertise to its affiliated physician groups, including clinical management, billing and collection, data warehousing, accounting, compliance and other administrative services. OnCURE is associated with a Medical Advisory Board comprised of all of the radiation oncologists whom provide medical services to the OnCURE facilities. Currently there are approximately 50 physicians on the Medical Advisory Board, and in addition, OnCURE has approximately 350 employees. For more information on OnCURE, please visit our web site at www.OnCURE.com.
OnCURE is a privately held company whose shareholders include Crossbow Ventures, Halpern Denny & Co. and MedEquity Capital, LLC.
About Crossbow Ventures: (www.crossbowventures.com)
Crossbow Ventures is a private equity investment firm founded by a former executive of Merrill Lynch Capital, and is based in Palm Beach, Florida. The firm has more than $170 million committed capital concentrated on lead investments located in the Southeast U.S. in Telecommunications, Information Technology, Life Sciences/Healthcare, and Financial Services sectors.
About Halpern, Denny & Co.: (www.halperndenny.com)
Halpern, Denny & Co. is a private equity investment firm founded by former executives of Bain & Company and Bain Capital. Based in Boston, the firm has more than $600 million committed capital to back strong management teams focused on driving their companies to leadership positions in their respective industries. Areas of investment focus include healthcare, media, distribution and consumer.
About MedEquity Capital, LLC: (www.medequity.com)
MedEquity Capital, LLC is a Wellesley, Massachusetts based private equity firm that provides expansion capital to emerging healthcare-related companies.
Forward-Looking Statements
Statements in this Press Release that are not historical facts constitute "forward-looking statements." Any statements contained herein which are not historical facts or which contain the words "anticipate," "believe," "continue," "estimate," "expect," "intend," "may," "should," and similar expressions are intended to identify forward-looking statements. Such statements reflect the current view of OnCURE with respect to future events and are subject to certain risks, uncertainties and assumptions, including, but not limited to, the risk that OnCURE may not be able to implement its growth strategy in the intended manner, including the ability to identify, finance, complete and integrate acquisitions and joint venture opportunities, risks regarding currently unforeseen competitive pressures and risks affecting OnCURE's industry, such as increased regulatory compliance and changes in regulatory requirements, changes in payor reimbursement levels and the development of additional alternative treatment modalities and technological changes. Should one or more of those risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described herein.
© 2006 Business Wire
